Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial (Q44846126)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2004
edit
Language Label Description Also known as
English
Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial
scientific article published in May 2004

    Statements

    Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial (English)
    Alan J Kivitz
    Maria W Greenwald
    Adam B Polis
    Daryl K Najarian
    Mary E Dixon
    Robert A Moidel
    Jerry A Green
    Herbert S B Baraf
    Richard A Petruschke
    Alan K Matsumoto
    Gregory P Geba
    Protocol 085 Study Investigators
    666-674

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit